ECOG-ACRIN adds another trial to the ComboMATCH precision oncology study platform
Another ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) treatment trial is open as part of the ComboMATCH precision medicine study platform. ComboMATCH-E5 is evaluating treatment for patients...
















